Christopher Wright
Direktor/Vorstandsmitglied bei ALKERMES PLC
Vermögen: 177 654 $ am 30.04.2024
Profil
Christopher I.
Wright is an Independent Director at Alkermes Plc and the Chief Medical Officer at Ring Therapeutics, Inc. He previously held positions as the SVP-Global Medicines Development & Medical Affairs at Vertex Pharmaceuticals, Inc., the Chief Development Officer & SVP-Global Development at Ironwood Pharmaceuticals, Inc., an Associate Professor at Harvard Medical School, the Chief Medical Officer & Senior Vice President at Axcella Health, Inc., the Chief Medical Officer & Senior Vice President at Cyclerion Therapeutics, Inc., and the Chief Medical Officer at Aavantibio, Inc. Dr. Wright received his undergraduate degree from Harvard University and his doctorate from Vrije Universiteit Amsterdam.
He also holds graduate and doctorate degrees from Harvard Medical School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
07.07.2023 | 7 269 ( 0,00% ) | 177 654 $ | 30.04.2024 |
Aktive Positionen von Christopher Wright
Unternehmen | Position | Beginn |
---|---|---|
ALKERMES PLC | Direktor/Vorstandsmitglied | 24.05.2022 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Christopher Wright
Unternehmen | Position | Ende |
---|---|---|
CYCLERION THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 26.03.2021 |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Technik-/Wissenschafts-/F&E-Leiter | - |
Harvard Medical School | Corporate Officer/Principal | - |
IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
AXCA HEALPAR | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Christopher Wright
Harvard University | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Vrije Universiteit Amsterdam | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
AXCA HEALPAR | Health Technology |
IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
CYCLERION THERAPEUTICS, INC. | Health Technology |
ALKERMES PLC | Health Technology |
Private Unternehmen | 2 |
---|---|
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |